DE2340060A1 - Magensaftresistente gelatinekapseln und verfahren zu deren herstellung - Google Patents
Magensaftresistente gelatinekapseln und verfahren zu deren herstellungInfo
- Publication number
- DE2340060A1 DE2340060A1 DE19732340060 DE2340060A DE2340060A1 DE 2340060 A1 DE2340060 A1 DE 2340060A1 DE 19732340060 DE19732340060 DE 19732340060 DE 2340060 A DE2340060 A DE 2340060A DE 2340060 A1 DE2340060 A1 DE 2340060A1
- Authority
- DE
- Germany
- Prior art keywords
- enteric
- layer
- methacrylic acid
- gelatin capsules
- intermediate layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title claims description 23
- 229920000159 gelatin Polymers 0.000 title claims description 20
- 235000019322 gelatine Nutrition 0.000 title claims description 20
- 238000000034 method Methods 0.000 title claims description 15
- 239000001828 Gelatine Substances 0.000 title claims description 10
- 238000004519 manufacturing process Methods 0.000 title description 5
- 239000010410 layer Substances 0.000 claims description 38
- 239000007903 gelatin capsule Substances 0.000 claims description 25
- 239000006185 dispersion Substances 0.000 claims description 23
- 239000011347 resin Substances 0.000 claims description 14
- 229920005989 resin Polymers 0.000 claims description 14
- 239000012055 enteric layer Substances 0.000 claims description 9
- -1 alkyl methacrylate Chemical compound 0.000 claims description 8
- 229920001577 copolymer Polymers 0.000 claims description 8
- 125000005397 methacrylic acid ester group Chemical group 0.000 claims description 8
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 6
- 229920006318 anionic polymer Polymers 0.000 claims description 6
- 229920006317 cationic polymer Polymers 0.000 claims description 6
- 230000007935 neutral effect Effects 0.000 claims description 6
- 125000005396 acrylic acid ester group Chemical group 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 3
- 125000003282 alkyl amino group Chemical group 0.000 claims 1
- 210000004051 gastric juice Anatomy 0.000 description 15
- 238000006386 neutralization reaction Methods 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 108010010803 Gelatin Proteins 0.000 description 10
- 239000008273 gelatin Substances 0.000 description 10
- 235000011852 gelatine desserts Nutrition 0.000 description 10
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 239000004922 lacquer Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 8
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 7
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 7
- 230000000968 intestinal effect Effects 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 230000002378 acidificating effect Effects 0.000 description 6
- 239000003973 paint Substances 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
- 230000001476 alcoholic effect Effects 0.000 description 4
- 230000001079 digestive effect Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000004014 plasticizer Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229920001800 Shellac Polymers 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 239000008298 dragée Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000007888 film coating Substances 0.000 description 3
- 238000009501 film coating Methods 0.000 description 3
- 125000005456 glyceride group Chemical group 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000004208 shellac Substances 0.000 description 3
- 235000013874 shellac Nutrition 0.000 description 3
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 3
- 229940113147 shellac Drugs 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 239000002966 varnish Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000001087 glyceryl triacetate Substances 0.000 description 2
- 235000013773 glyceryl triacetate Nutrition 0.000 description 2
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 2
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 2
- 239000011229 interlayer Substances 0.000 description 2
- 150000004667 medium chain fatty acids Chemical class 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229920000151 polyglycol Polymers 0.000 description 2
- 239000010695 polyglycol Substances 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 229960002622 triacetin Drugs 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- RWHRFHQRVDUPIK-UHFFFAOYSA-N 50867-57-7 Chemical compound CC(=C)C(O)=O.CC(=C)C(O)=O RWHRFHQRVDUPIK-UHFFFAOYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 241000978776 Senegalia senegal Species 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000159 acid neutralizing agent Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001278 adipic acid derivatives Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- GDCRSXZBSIRSFR-UHFFFAOYSA-N ethyl prop-2-enoate;2-methylprop-2-enoic acid Chemical compound CC(=C)C(O)=O.CCOC(=O)C=C GDCRSXZBSIRSFR-UHFFFAOYSA-N 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- IQSHMXAZFHORGY-UHFFFAOYSA-N methyl prop-2-enoate;2-methylprop-2-enoic acid Chemical compound COC(=O)C=C.CC(=C)C(O)=O IQSHMXAZFHORGY-UHFFFAOYSA-N 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 150000003021 phthalic acid derivatives Chemical class 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 150000003329 sebacic acid derivatives Chemical class 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
- Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2991—Coated
- Y10T428/2998—Coated including synthetic resin or polymer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/31504—Composite [nonstructural laminate]
- Y10T428/31725—Of polyamide
- Y10T428/3175—Next to addition polymer from unsaturated monomer[s]
- Y10T428/31754—Natural source-type polyamide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/31504—Composite [nonstructural laminate]
- Y10T428/31855—Of addition polymer from unsaturated monomers
- Y10T428/31909—Next to second addition polymer from unsaturated monomers
- Y10T428/31928—Ester, halide or nitrile of addition polymer
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19732340060 DE2340060A1 (de) | 1973-08-08 | 1973-08-08 | Magensaftresistente gelatinekapseln und verfahren zu deren herstellung |
| NL7409483A NL7409483A (nl) | 1973-08-08 | 1974-07-12 | Tegen maagsap resistente gelatinecapsules. |
| FR7427080A FR2239991A1 (cg-RX-API-DMAC7.html) | 1973-08-08 | 1974-08-05 | |
| US05/495,896 US3959540A (en) | 1973-08-08 | 1974-08-08 | Gastric juice resistant gelatin capsules and a process for the production thereof |
| BE147413A BE818628A (fr) | 1973-08-08 | 1974-08-08 | Capsules de gelatine resistant au suc gastrique et leur preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19732340060 DE2340060A1 (de) | 1973-08-08 | 1973-08-08 | Magensaftresistente gelatinekapseln und verfahren zu deren herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2340060A1 true DE2340060A1 (de) | 1975-02-20 |
Family
ID=5889166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19732340060 Pending DE2340060A1 (de) | 1973-08-08 | 1973-08-08 | Magensaftresistente gelatinekapseln und verfahren zu deren herstellung |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US3959540A (cg-RX-API-DMAC7.html) |
| BE (1) | BE818628A (cg-RX-API-DMAC7.html) |
| DE (1) | DE2340060A1 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2239991A1 (cg-RX-API-DMAC7.html) |
| NL (1) | NL7409483A (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0403959A1 (de) * | 1989-06-20 | 1990-12-27 | Röhm Gmbh | Filmbildendes wässriges Überzugsmittel für feste Arzneimittel, Verfahren zu seiner Herstellung und Verwendung |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2543542C2 (de) * | 1975-09-30 | 1986-10-02 | Röhm GmbH, 6100 Darmstadt | Verfahren zur Herstellung eines Plastisols |
| US4088798A (en) * | 1975-11-11 | 1978-05-09 | Sandoz, Inc. | Methods for the preparation of controlled gastric residence time medicament formulations |
| SE8003805L (sv) * | 1980-05-21 | 1981-11-22 | Haessle Ab | En farmaceutisk beredning med forbettrade utlosningsegenskap |
| DE3106449A1 (de) * | 1981-02-20 | 1982-09-09 | Röhm GmbH, 6100 Darmstadt | "in magensaft loesliche oder quellbare ueberzugsmasse und ihre verwendung in einem verfahren zum ueberziehen von arzneiformen" |
| JPS5973529A (ja) * | 1982-10-12 | 1984-04-25 | Sankyo Co Ltd | 被覆固形製剤の製造法 |
| US4708867A (en) * | 1983-12-19 | 1987-11-24 | Key Pharmaceuticals, Inc. | Minipellets |
| US4800087A (en) * | 1986-11-24 | 1989-01-24 | Mehta Atul M | Taste-masked pharmaceutical compositions |
| US4816259A (en) * | 1987-02-12 | 1989-03-28 | Chase Chemical Company, L.P. | Process for coating gelatin capsules |
| US5064650A (en) * | 1988-04-19 | 1991-11-12 | Southwest Research Institute | Controlled-release salt sensitive capsule for oral use and adhesive system |
| US5972685A (en) * | 1988-07-21 | 1999-10-26 | Iowa State University Research Foundation, Inc. | Oral administration of coprostanol producing microorganisms to humans to decrease plasma cholesterol concentration |
| US5436004A (en) * | 1988-07-21 | 1995-07-25 | Iowa State University Research Foundation, Inc. | Administration of cholesterol reductase to humans |
| US4921710A (en) * | 1988-07-21 | 1990-05-01 | Iowa State University Research Foundation, Inc. | Method of converting cholesterol in food to coprostanol |
| US5084278A (en) * | 1989-06-02 | 1992-01-28 | Nortec Development Associates, Inc. | Taste-masked pharmaceutical compositions |
| US5198227A (en) * | 1990-01-22 | 1993-03-30 | Mcneil-Ppc, Inc. | Dual subcoated simulated capsule medicament |
| IT1245890B (it) * | 1991-04-12 | 1994-10-25 | Alfa Wassermann Spa | Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari. |
| IT1245891B (it) * | 1991-04-12 | 1994-10-25 | Alfa Wassermann Spa | Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali. |
| US5314696A (en) * | 1991-06-27 | 1994-05-24 | Paulos Manley A | Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor |
| US5364634A (en) * | 1991-11-08 | 1994-11-15 | Southwest Research Institute | Controlled-release PH sensitive capsule and adhesive system and method |
| GB9223172D0 (en) * | 1992-11-05 | 1992-12-16 | Scherer Corp R P | Capsule construction |
| DE4329503A1 (de) * | 1993-09-01 | 1995-03-02 | Galenik Labor Freiburg Gmbh | Pharmazeutische Präparate zur gezielten Behandlung von Morbus Crohn und Colitis Ulcerosa |
| US6204243B1 (en) | 1993-09-01 | 2001-03-20 | Novatis Ag | Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis |
| GB2290965A (en) * | 1994-07-11 | 1996-01-17 | Therapicon Srl | Multiple layer capsules for drugs |
| US5674488A (en) * | 1994-10-07 | 1997-10-07 | Reich; John J. | Method for prevention and treatment of hyperchlolesterolemia by in vivo hydrogenation of cholesterol |
| US20040018236A1 (en) * | 1995-05-08 | 2004-01-29 | Robert Gurny | Nanoparticles for oral administration of pharmaceutical agents of low solubility |
| NL1009107C2 (nl) * | 1997-11-12 | 1999-06-15 | Banner Pharmacaps Inc | Gelatine-uitspreidende doos met meervoudige, aanpasbare poortklep en meerlagig zacht gel. |
| US6193999B1 (en) | 1999-03-01 | 2001-02-27 | Banner Pharmacaps, Inc. | Gum acacia substituted soft gelatin capsules |
| US6551617B1 (en) | 2000-04-20 | 2003-04-22 | Bristol-Myers Squibb Company | Taste masking coating composition |
| DE60128215T2 (de) | 2000-04-20 | 2008-01-10 | Novartis Ag | Beschichtungszusammensetzung zur geschmacksmaskierung |
| US6858666B2 (en) | 2002-03-04 | 2005-02-22 | Aveka, Inc. | Organogel particles |
| JP4790219B2 (ja) | 2002-03-26 | 2011-10-12 | ユーロ−セルティーク エス．エイ． | 徐放性ゲルコーティング組成物 |
| AU2003251377A1 (en) * | 2002-08-14 | 2004-03-03 | Quest International Services B.V. | Compositions comprising encapsulated material |
| DK2772250T3 (en) * | 2002-10-01 | 2016-12-05 | Banner Life Sciences Llc | Enteric composition for the manufacture of soft capsule wall |
| US9254270B2 (en) * | 2002-10-01 | 2016-02-09 | Banner Life Sciences Llc | Enteric soft capsules |
| CA2950203C (en) | 2014-06-20 | 2019-09-03 | Banner Life Sciences Llc | Enteric soft capsule compositions |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3070509A (en) * | 1958-12-18 | 1962-12-25 | Roehm & Haas Gmbh | Process for coating medicaments |
| DE1617671C3 (de) * | 1967-03-07 | 1980-07-03 | A. Nattermann & Cie Gmbh, 5000 Koeln | Weichgelatine-Kapseln mit erhöhter Wärmestabilität |
| YU36434B (en) * | 1969-05-14 | 1984-02-29 | Sanol Arznei Schwarz Gmbh | Process for obtaining gelation capsules filled with the active substance resistant to gastric juice and dissolvable in the small intestine |
| DE2135073C3 (de) * | 1971-07-14 | 1974-07-11 | Roehm Gmbh | Überzugsmittel für Arzneiformen |
-
1973
- 1973-08-08 DE DE19732340060 patent/DE2340060A1/de active Pending
-
1974
- 1974-07-12 NL NL7409483A patent/NL7409483A/xx unknown
- 1974-08-05 FR FR7427080A patent/FR2239991A1/fr not_active Withdrawn
- 1974-08-08 US US05/495,896 patent/US3959540A/en not_active Expired - Lifetime
- 1974-08-08 BE BE147413A patent/BE818628A/xx unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0403959A1 (de) * | 1989-06-20 | 1990-12-27 | Röhm Gmbh | Filmbildendes wässriges Überzugsmittel für feste Arzneimittel, Verfahren zu seiner Herstellung und Verwendung |
| DE3920082A1 (de) * | 1989-06-20 | 1991-03-07 | Roehm Gmbh | Filmbildendes waessriges ueberzugsmittel fuer feste arzneimittel, verfahren zu seiner herstellung und verwendung |
Also Published As
| Publication number | Publication date |
|---|---|
| NL7409483A (nl) | 1975-02-11 |
| US3959540A (en) | 1976-05-25 |
| FR2239991A1 (cg-RX-API-DMAC7.html) | 1975-03-07 |
| BE818628A (fr) | 1974-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2340060A1 (de) | Magensaftresistente gelatinekapseln und verfahren zu deren herstellung | |
| DE69230028T3 (de) | Methode um eine stabilisierte Formulierung mit kontrollierter Abgabe mit einem Acrylpolymerüberzug zu erhalten | |
| DE69619668T2 (de) | Pharmazeutische dosisform mit mehrfacher darmlöslicher polymerbeschichtung zur wirkstoffabgabe im kolon | |
| DE69630215T2 (de) | Diltiazem-formulierung mit gesteuerter freigabe | |
| DE60106889T2 (de) | Verfahren zur herstellung eines tabletts mit kontrollierter freisetzung mit der verwendung von einem porenbildenden agens in der beschichtung | |
| DE60003396T2 (de) | Bupropion-darreichungsform mit kontrollierter freisetzung | |
| DE69122751T2 (de) | Arzneimittelzusammensetzung mit kontrollierter wirkstoffabgabe | |
| EP0032562B1 (de) | Neue Dipyridamol-Retardformen und Verfahren zu ihrer Herstellung | |
| DE69310461T2 (de) | Weiche Kapseln mit Magensaftresistentem Überzug und Verfahren zu ihrer Herstellung | |
| DE19626045C2 (de) | Stabile Arzneiform zur oralen Verabreichung, welche Omeprazol als aktiven Wirkstoff enthält, sowie Verfahren zur Herstellung derselben | |
| DE69729950T2 (de) | Arzneimittel-Zuführsystem mit verzögerter Freisetzung für säurelabile Arzneistoffe | |
| DE2336218B2 (de) | Neue orale Arzneiform und Verfahren zu ihrer Herstellung | |
| DE60038447T2 (de) | Stabile benzimidazol zusammensetzungen | |
| DE2651176A1 (de) | Mittel mit geregelter wirkstoffabgabe und verfahren zu dessen herstellung | |
| DD232646A5 (de) | Waessrige dispersion eines ueberzugmittels fuer arzneiformen | |
| WO1992022284A1 (de) | Pantoprazol enthaltende orale darreichungsformen | |
| DE2031871B2 (de) | Überzugsmasse fur Arzneiformen | |
| DE9414066U1 (de) | Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform | |
| CH649216A5 (de) | Verfahren zur auftragung eines magensaftresistenten filmes auf einen heilmittelkern und feste einheitsdosierungsform mit magensaftresistentem film. | |
| DE2741755A1 (de) | Ueberzugsmassen auf polymerbasis fuer biologisch aktive praeparate und verfahren zur herstellung der ersteren sowie biologisch aktive praeparate und verfahren zur herstellung der letzteren | |
| EP0184754A2 (de) | Pankreasenzympräparate und Verfahren zu deren Herstellung | |
| WO2003075898A2 (de) | Filmüberzüge mit kontrollierter freisetzung und hoher stabilität | |
| DE2732335C2 (de) | Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten | |
| EP0208213B1 (de) | Arzneimittelumhüllung | |
| DE2616748C2 (de) | Darmlösliche pharmazeutische Kapseln |